Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Cell

• Publication date

  2004-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.CCR.2004.09.028PMID 15542429
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oncogenes and Tumor Angiogenesis

  2004cited by this paper
• Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis

  2004cited by this paper
• Advances in protein kinase B signalling: AKTion on multiple fronts.

  2004cited by this paper
• Oncogenes and tumor angiogenesis: the question of vascular "supply" and vascular "demand".

  2004cited by this paper
• A Genetically Defined Model for Human Ovarian Cancer

  2004cited by this paper
• Phosphoinositide 3‐kinase‐dependent activation of Rac

  2003cited by this paper
• Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis.

  2003cited by this paper
• Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes

  2002cited by this paper
• The Bax Subfamily of Bcl2-Related Proteins Is Essential for Apoptotic Signal Transduction by c-Jun NH2-Terminal Kinase

  2002cited by this paper
• Inflammation and cancer

  2002cited by this paper
• Detailed genomic mapping and expression analyses of 12p amplifications in pancreatic carcinomas reveal a 3.5‐Mb target region for amplification

  2002cited by this paper
• New functions for the matrix metalloproteinases in cancer progression

  2002cited by this paper
• Multiple control of interleukin‐8 gene expression

  2002cited by this paper
• VEGF and the quest for tumour angiogenesis factors

  2002cited by this paper
• Interleukin 8 is an autocrine growth factor and a surrogate marker for Kaposi's sarcoma.

  2001cited by this paper
• Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy

  2001cited by this paper
• A Ras by Any Other Name

  2001cited by this paper
• Signal Transduction Pathways Mediating Neurotensin-stimulated Interleukin-8 Expression in Human Colonocytes*

  2001cited by this paper
• Analysis of the transcriptional program induced by Raf in epithelial cells

  2001cited by this paper
• MAPK and Akt act cooperatively but independently on hypoxia inducible factor-1alpha in rasV12 upregulation of VEGF.

  2001cited by this paper
• Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials.

  2001cited by this paper
• Genetic Basis of Pituitary Adenoma Invasiveness: A Review

  2001cited by this paper
• The microenvironment of the tumour–host interface

  2001cited by this paper
• MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis.

  2000cited by this paper
• Rho GTPases: signaling, migration, and invasion.

  2000cited by this paper
• Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.

  2000cited by this paper
• Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts.

  2000cited by this paper
• MMP-9 Supplied by Bone Marrow – Derived Cells Contributes to Skin Carcinogenesis

  2000cited by this paper
• Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

  2000cited by this paper
• Molecular Regulation of Constitutive Expression of Interleukin-8 in Human Pancreatic Adenocarcinoma

  2000cited by this paper
• Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis.

  1999cited by this paper
• Expression of interleukin-8 in primary and metastatic malignant melanoma of the skin.

  1999cited by this paper
• NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling.

  1999cited by this paper
• Oncogenic ras fails to restore an in vivo tumorigenic phenotype in embryonic stem cells lacking vascular endothelial growth factor (VEGF).

  1999cited by this paper
• Role of Interleukin-8 in Tumor Growth and Metastasis of Human Melanoma

  1999cited by this paper
• Henry Spira's Search for Common Ground on Animal Testing

  1999cited by this paper
• Biological implications of macrophage infiltration in human tumor angiogenesis

  1999cited by this paper
• OncogenicrasFails to Restore anin VivoTumorigenic Phenotype in Embryonic Stem Cells Lacking Vascular Endothelial Growth Factor (VEGF)

  1999cited by this paper
• Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic.

  1999cited by this paper
• Essential role for oncogenic Ras in tumour maintenance

  1999cited by this paper
• Expression of interleukin‐8 detected by in situ hybridization correlates with worse prognosis in primary cutaneous melanoma

  1999cited by this paper
• NF-κB is a target of AKT in anti-apoptotic PDGF signalling

  1999cited by this paper
• Increasing complexity of Ras signaling

  1998cited by this paper
• Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions.

  1998cited by this paper
• Expression of interleukin-8 correlates with vascularity in human gastric carcinomas.

  1998cited by this paper
• Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells.

  1998cited by this paper
• Changes of cytokines and thyroid function in patients with recurrent breast cancer.

  1997cited by this paper
• Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways.

  1997cited by this paper
• Direct Regulation of the Akt Proto-Oncogene Product by Phosphatidylinositol-3,4-bisphosphate

  1997cited by this paper
• Cell cycle: routine role for Ras.

  1997cited by this paper
• Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins.

  1997cited by this paper
• Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB

  1997cited by this paper
• Oct-1 and CCAAT/Enhancer-binding Protein (C/EBP) Bind to Overlapping Elements within the Interleukin-8 Promoter

  1997cited by this paper
• Induction of Vascular Endothelial Growth Factor by Tumor Necrosis Factor α in Human Glioma Cells(ヒトグリオーマ細胞における腫瘍壊死因子αによる血管内皮増殖因子の誘導)

  1997cited by this paper
• Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1.

  1996cited by this paper
• Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression.

  1996cited by this paper
• Induction of Vascular Endothelial Growth Factor by Tumor Necrosis Factor α in Human Glioma Cells

  1996cited by this paper
• Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis.

  1995cited by this paper
• Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation

  1995cited by this paper
• Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis

  1995cited by this paper
• ERK phosphorylation potentiates Elk‐1‐mediated ternary complex formation and transactivation.

  1995cited by this paper
• The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway.

  1995cited by this paper
• Serum levels of cytokines in patients with colorectal cancer: Possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis

  1994cited by this paper
• Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma

  1994cited by this paper
• The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain.

  1993cited by this paper
• Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8.

  1993cited by this paper
• IL-4 regulates the morphology, cytoskeleton, and proliferation of human umbilical vein endothelial cells: relationship between vimentin and CD23.

  1993cited by this paper
• Interleukin-8 as a macrophage-derived mediator of angiogenesis.

  1992cited by this paper
• Characterization of GRO α, β and γ expression in human colonic tumours: potential significance of cytokine involvement

  1992cited by this paper
• Characterization of GRO alpha, beta and gamma expression in human colonic tumours: potential significance of cytokine involvement.

  1992cited by this paper
• Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kB-like binding sites of the interleukin 8 gene.

  1992cited by this paper
• ras oncogenes in human cancer: a review.

  1989cited by this paper
• Ras oncogene mediated induction of a 92 kDa metalloproteinase; strong correlation with the malignant phenotype.

  1988cited by this paper
• Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor

  1988cited by this paper
• Mast‐cell‐deficient W/Wv mice exhibit A decreased rate of tumor angiogenesis

  1988cited by this paper
• ras gene alterations and enhanced levels of ras p21 expression in a spectrum of benign and malignant human mammary tissues.

  1986cited by this paper

• Unravelling Resistance: Integrating Metabolism, Epigenetics, Immunology, and Proteostasis in Strategies against Kirsten Rat Sarcoma Viral Oncogene Homolog-mutant Colorectal Cancer

  2026cites this paper
• Impact of Chronic Stress and Anxiety on Interleukin-6, Hypoxia-Inducible Factor-1α and on Pathological and Immunohistochemical Parameters in Breast Cancer

  2025cites this paper
• CXCL8 is essential for cervical cancer cell acquired radioresistance and acts as a promising therapeutic target in cervical cancer

  2025cites this paper
• MiRNA affects the advancement of breast cancer by modulating the immune system's response.

  2025cites this paper
• Neutrophils in Tissue Injury and Repair: Molecular Mechanisms and Therapeutic Targets

  2025cites this paper
• Elucidating Ras protein as a dual therapeutic target for inflammation and cancer: a review

  2025cites this paper
• Targeting CXCR2 signaling in inflammatory lung diseases: neutrophil-driven inflammation and emerging therapies

  2025cites this paper
• Predictive model for very early recurrence of patients with perihilar cholangiocarcinoma: a machine learning approach

  2025cites this paper
• Prognostic Significance of Neutrophil‐to‐Lymphocyte Ratio in Melanoma: A Systematic Review and Meta‐Analysis

  2025cites this paper
• "Biological R2" resection for intrahepatic cholangiocarcinoma: identification of patients at risk for poor oncologic outcomes after curative-intent resection.

  2025cites this paper
• Targeting oxidative stress-mediated regulated cell death as a vulnerability in cancer

  2025cites this paper
• Current status of KRAS G12C inhibitors in NSCLC and the potential for combination with anti-PD-(L)1 therapy: a systematic review

  2025cites this paper
• Advancements in gene therapies targeting mutant KRAS in cancers

  2025cites this paper
• Targeting neutrophils for cancer therapy

  2025cites this paper
• The chemotherapy-induced senescence-associated secretome promotes cell detachment and metastatic dissemination through metabolic reprogramming

  2025cites this paper
• Supplementation with N-Acetyl-L-cysteine during in vitro maturation improves goat oocyte developmental competence by regulating oxidative stress.

  2025cites this paper
• Precision immune regulation in KRAS-mutated cancers: the final piece of the puzzle?

  2025cites this paper
• Evolution of direct RAS inhibitors: from undruggable target to clinical breakthroughs

  2025cites this paper
• Inflammation in cancer: therapeutic opportunities from new insights

  2025cites this paper
• Drugging the ‘undruggable’ KRAS: breakthroughs, challenges, and opportunities in pancreatic cancer

  2025cites this paper
• Dynamic Multilevel Regulation of EGFR, KRAS, and MYC Oncogenes: Driving Cancer Cell Proliferation Through (Epi)Genetic and Post-Transcriptional/Translational Pathways

  2025cites this paper
• Shaping the battlefield: EGFR and KRAS tumor mutations’ role on the immune microenvironment and immunotherapy responses in lung cancer

  2025cites this paper
• Zinc Finger Proteins in Colorectal Cancer: Insights into Molecular Mechanisms and Therapeutic Implications

  2025cites this paper
• Clinical Potential of YY1-Hypoxia Axis for Vascular Normalization and to Improve Immunotherapy

  2024cites this paper
• Brain injury drives optic glioma formation through neuron-glia signaling

  2024cites this paper
• Enhanced CCR2 expression by ACKR2-deficient NK cells increases tumoricidal cell therapy efficacy.

  2024cites this paper
• Decoding potential targets and pharmacologic mechanisms of curcumin in treating non-small cell lung carcinoma via bioinformatics and molecular docking

  2024cites this paper
• Salivary Biomarkers for Oral Cancer Detection: An Exploratory Systematic Review

  2024cites this paper
• The next-generation KRAS inhibitors…What comes after sotorasib and adagrasib?

  2024cites this paper
• Immunosurveillance encounters cancer metabolism

  2024cites this paper
• Role of chemokines in aging and age-related diseases.

  2024cites this paper
• Cellular senescence and its pathogenic and therapeutic implications in autoimmune hepatitis

  2024cites this paper
• Comprehensive Analysis Reveals No Significant Correlation Between p16/ CDKN2A Expression and Treatment Outcomes in Laryngeal Squamous Cell Carcinoma

  2024cites this paper
• Fungal influence on immune cells and inflammatory responses in the tumor microenvironment (Review).

  2024cites this paper
• The CXCR2 chemokine receptor: A new target for gastric cancer therapy.

  2024cites this paper
• A key regulator of tumor-associated neutrophils: the CXCR2 chemokine receptor

  2024cites this paper
• Role of Epiregulin on Lipopolysaccharide-Induced Hepatocarcinogenesis as a Mediator via EGFR Signaling in the Cancer Microenvironment

  2024cites this paper
• 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol treatment inhibits abnormal tumor growth by regulating neutrophil infiltration in a non-small cell lung carcinoma mouse model.

  2024cites this paper
• MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer

  2024cites this paper
• How Oxidative Stress Modifies the Immune Response Landscape in Cancer

  2024cites this paper
• Studying Progression from Chronic Injury to Esophageal Adenocarcinoma

  2024cites this paper
• ROS: A "booster" for chronic inflammation and tumor metastasis.

  2024cites this paper
• Deciphering Natural Killer Cell Cytotoxicity Against Medulloblastoma in vitro and in vivo: Implications for Immunotherapy

  2024cites this paper
• Senescence: Definition, mechanisms of occurence and detection in tissues

  2024cites this paper
• Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within interleukin-6 family cytokines

  2024cites this paper
• Targeting KRAS and SHP2 signaling pathways for immunomodulation and improving treatment outcomes in solid tumors.

  2024cites this paper
• Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer

  2024cites this paper
• Exploiting the therapeutic implications of KRAS inhibition on tumor immunity.

  2024cites this paper
• T‐Rex escaped from the cytosolic park: Re‐thinking the impact of TREX1 exonuclease deficiencies on genomic stability

  2024cites this paper
• Targeting KRAS mutations in pancreatic cancer: opportunities for future strategies

  2024cites this paper
• Immune status and combined immunotherapy progression in Kirsten rat sarcoma viral oncogene homolog (KRAS)-mutant tumors.

  2024cites this paper
• Oncogenic RAS in Cancers from the DNA Replication Stress and Senescence Perspective

  2024cites this paper
• The significance of preoperative neutrophil-to-lymphocyte ratio in predicting short-term complications and survival benefits of pancreaticoduodenectomy: A systematic review and meta-analysis.

  2023cites this paper
• Exploring the role of the disulfidptosis-related gene SLC7A11 in adrenocortical carcinoma: implications for prognosis, immune infiltration, and therapeutic strategies

  2023cites this paper
• Prognostic value of lymphocyte-to-monocyte ratio in gastric cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis

  2023cites this paper
• New insights into RAS in head and neck cancer.

  2023cites this paper
• Facts and Hopes on RAS Inhibitors and Cancer Immunotherapy

  2023cites this paper
• Serum CXCL8 and CXCR2 as diagnostic biomarkers for noninvasive screening of cervical cancer

  2023cites this paper
• The aged extracellular matrix and the pro-fibrotic role of senescence -associated secretory phenotype (SASP).

  2023cites this paper
• Role and Expression Regulation of Interleukin-8 in Inflammatory Reaction

  2023cites this paper
• Cytosolic EpCAM cooperates with H-Ras to regulate epithelial to mesenchymal transition through ZEB1

  2023cites this paper
• Monocyte depletion enhances neutrophil influx and proneural to mesenchymal transition in glioblastoma

  2023cites this paper
• P2Y11/IL-1 receptor crosstalk controls macrophage inflammation: a novel target for anti-inflammatory strategies?

  2023cites this paper
• Therapeutic inhibition of CXCR1/2: where do we stand?

  2023cites this paper
• Heterogeneity of Extracellular Vesicles and Particles: Molecular Voxels in the Blood Borne “Hologram” of Organ Function, Disfunction and Cancer

  2023cites this paper
• Optic tract edema in craniopharyngioma as a predictor of BRAFV600E mutation presence.

  2023cites this paper
• Transcriptional Regulation during Aberrant Activation of NF-κB Signalling in Cancer

  2023cites this paper
• Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment

  2023cites this paper
• Expanding role of CXCR2 and therapeutic potential of CXCR2 antagonists in inflammatory diseases and cancers.

  2023cites this paper
• Development of alternative herbals remedy for gastric cancer based on transcriptomic analysis of immune infiltration and ferroptosis

  2023cites this paper
• Transcriptional landscape of oncogene-induced senescence: a machine learning based meta analytic approach.

  2023cites this paper
• Monocyte-neutrophil entanglement in glioblastoma

  2023cites this paper
• Mechanisms driving the immunoregulatory function of cancer cells

  2023cites this paper
• Tumor Promoting Inflammation

  2023cites this paper
• Diallyl Disulfide Blocks Cigarette Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone-Induced Lung Tumorigenesis via Activation of the Nrf2 Antioxidant System and Suppression of NF-κB Inflammatory Response.

  2023cites this paper
• Could senescence phenotypes strike the balance to promote tumor dormancy?

  2023cites this paper
• Onco-immunomodulatory properties of pharmacological interference with RAS-RAF-MEK-ERK pathway hyperactivation

  2022cites this paper
• Identification of genomic determinants contributing to cytokine release in immunotherapies and human diseases

  2022cites this paper
• Detection of IL1β Gene in Sudanese Patients with Gliomas Tumor in Khartoum state, Sudan

  2022cites this paper
• Molecular Biology and Therapeutic Perspectives for K-Ras Mutant Non-Small Cell Lung Cancers

  2022cites this paper
• DIVERSITY OF RIBONUCLEIC ACID (RNA) VIRUS ENDOGENOUS VIRAL ELEMENTS (EVEs) IN INSECT GENETIC MATERIAL

  2022cites this paper
• Neutrophil phenotypes and functions in cancer: A consensus statement

  2022cites this paper
• Therapeutic Effects of Natural Products on Cervical Cancer: Based on Inflammatory Pathways

  2022cites this paper
• O Processo de Envelhecimento e o Cuidado Humanizado do Idoso Cardiopata: Um Breve Ensaio de Atualização / The aging process and the humanized care of the elderly with heart disease: a brief essay

  2022cites this paper
• Neurodevelopmental disorders, immunity, and cancer are connected

  2022cites this paper
• Chemokines as Regulators of Neutrophils: Focus on Tumors, Therapeutic Targeting, and Immunotherapy

  2022cites this paper
• Inflammation and Myeloid Cells in Cancer Progression and Metastasis

  2022cites this paper
• EMT-mediated regulation of CXCL1/5 for resistance to anti-EGFR therapy in colorectal cancer

  2022cites this paper
• Human endothelial cells promote arsenic-transformed lung epithelial cells to induce tumor growth and angiogenesis through interleukin-8 induction

  2022cites this paper
• Characterization With KRAS Mutant Is a Critical Determinant in Immunotherapy and Other Multiple Therapies for Non-Small Cell Lung Cancer

  2022cites this paper
• Caspase‐4/11 is critical for angiogenesis by repressing Notch1 signalling via inhibiting γ‐secretase activity

  2022cites this paper
• Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8

  2022cites this paper
• Role of extracellular vesicles in cancer-specific interactions between tumour cells and the vasculature.

  2022cites this paper
• Effects of Circulating Exosomes on B cells in Head and Neck Squamous Cell Carcinoma

  2022cites this paper
• Targeting of the ELR+CXCL/CXCR1/2 Pathway Is a Relevant Strategy for the Treatment of Paediatric Medulloblastomas

  2022cites this paper
• Aging of Liver in Its Different Diseases

  2022cites this paper
• The bromodomain protein TRIM28 controls the balance between growth and invasiveness in melanoma

  2022cites this paper
• RAS: Circuitry and therapeutic targeting.

  2022cites this paper
• Senolytic Therapy: A Potential Approach for the Elimination of Oncogene-Induced Senescent HPV-Positive Cells

  2022cites this paper
• Inorganic arsenic exposure-induced premature senescence and senescence-associated secretory phenotype (SASP) in human hepatic stellate cells.

  2022cites this paper